HomeVicarious Surgical Confronts NYSE Delisting Notice
Vicarious Surgical's Beta 2 robotic surgery system. | Credit: Vicarious Surgical
Vicarious Surgical (NYSE:RBOT) has been notified by the New York Stock Exchange (NYSE) that it is initiating procedures to delist the company's stock.
The surgical robotics company, based in Waltham, Massachusetts, received the formal notice from the exchange on March 3, 2026. Consequently, trading of the company's shares was suspended at the close of the market that day.
RBOT shares are currently priced at $1.92 each ahead of the NYSE market opening today.
Vicarious stated that the NYSE made its determination because the company's stock failed to meet the continued listing requirement. This standard mandates that listed companies maintain a minimum average global market capitalization of $15 million over a consecutive 30-trading-day period.
The company has a 10-business-day window to appeal the decision following receipt of the notice. Vicarious indicated it is currently evaluating a potential appeal. In the interim, the company has secured approval for its stock to be quoted on the OTCIQ market tier, operated by OTC Markets Group. It anticipates its common stock will begin trading on that platform at the market open today, March 4, 2026, and plans to continue using the "RBOT" ticker symbol.
This marks a second confrontation with delisting for the company, which also fell below NYSE standards in 2023. It subsequently executed a reverse stock split in mid-2024 to regain compliance.
Recent developments at Vicarious Surgical
The potential delisting occurs at a pivotal moment for Vicarious. The company has been progressing with its surgical robotics platform for several years, though the journey has encountered multiple delays.
The Vicarious robot is engineered to improve the efficiency of surgical operations. The company initially targeted the first-in-human trials for mid-2025 but postponed the timeline in November 2023. By March 2024, Vicarious outlined a revised plan to prepare its "V1.0" system for an FDA submission in early to mid-fiscal 2026.
In late 2024, the company announced intentions to conduct a year-end cadaver lab for the V1.0 system. This would be followed by verification, validation, and optimization work prior to formal clinical trials. A new hospital partnership was revealed in May 2025, representing a step toward deploying the surgical robot. However, in August of that year, Vicarious decided to defer the start of clinical trials to allow for further robot development, setting a target for a final design freeze by the end of 2026.
Earlier this year, the company successfully conducted an in-vivo porcine lab study for its robot. According to Vicarious, this achievement supports its ongoing progress toward the planned system design freeze scheduled for late 2026.
Related article
Apple Smart Glasses Could Debut at WWDC27, Highlighting Privacy Protection
Bloomberg’s Mark Gurman reports that Apple’s smart glasses, codenamed N50, are slated for a WWDC27 debut in June 2027, with a retail launch expected in autumn 2027. Originally targeted for late this year and early 2027, the device’s release has been
Inside Details Exposed About Next-Gen Gemini: Strained Computing Power, Internal Teams Disagreed on Development Priorities and Resource Allocation
Reports indicate that the launch of Google’s highly anticipated next-generation Gemini model has been pushed back. Internal disagreements over development priorities and resource allocation, combined with limited computing capacity and complex approv
OpenAI Dismisses Growth Slowdown Concerns, Says Multiple Business Units Accelerating
In response to external scrutiny regarding decelerating sales growth and missed internal benchmarks, AI leader OpenAI issued a confident statement on Tuesday, April 28. The company clarified that its consumer products and enterprise services are adva
Related Special Topic Recommendations
Data Analysis
AI SQL Copilots for Revenue Dashboards, Funnel Analysis, and Product Metrics
2026 Latest Best AI SQL Copilots Ranked Top-Rated! XIX.AI curates a powerful game-changing collection for weekly updated real-world tests. These must-try tools help you generate accurate revenue dashboards, analyze sales funnels, and track product metrics swiftly, boosting productivity massively. Explore now to Discover your perfect tool for data-driven decision making! 238 characters
9 tools
xix.ai
Music composition
Best AI Melody Writing Tools for Song Drafts
2026 Latest Best Top-Rated AI Melody Writing Tools for Song Drafts! XIX.AI has curated a highly powerful game-changing collection that goes through rigorous real-world tests to deliver the best writing experience. You can find detailed free vs paid comparisons, accurate rankings, and must-try options designed to help you create stunning song drafts effortlessly and boost your creative productivity significantly. Explore now to discover your perfect tool!
8 tools
xix.ai
chatbot
Best AI Conversation Trainer Tools for Interview Practice
2026 Latest Best Top-rated AI Conversation Trainer Tools for Interview Practice are here on XIX.AI! This curated collection features powerful, game-changing tools that go through rigorous real-world tests to deliver accurate feedback. You’ll find a free vs paid comparison and detailed rankings to help you choose the must-try option that boosts your confidence and skills. Explore now to Discover your perfect tool for interview success!
12 tools
xix.ai
Design & Art
Best AI Style Transfer Tools for Creative Experiments
2026 Latest Best Top-rated AI Style Transfer Tools for Creative Experiments! XIX.AI has curated a powerful, game-changing collection of must-try tools that deliver exceptional results through real-world tests and rigorous rankings. These top solutions help creatives boost productivity significantly by accelerating content creation and unlocking endless creative possibilities. Explore now to discover your perfect tool and start creating today!
9 tools
xix.ai
Comic Creation
Best AI Dialogue Bubble Tools for Visual Storytelling
2026 Latest Best Top-Rated AI Dialogue Bubble Tools for Visual Storytelling are here on XIX.AI! This curated collection features powerful, game-changing tools that help creators boost productivity and overcome creative bottlenecks. Get a free vs paid comparison, see real-world tests, and check the latest rankings to find the must-try solutions perfect for crafting engaging visual narratives. Explore now to discover your ideal tool!
10 tools
xix.ai
Meeting Assistant
Top AI Meeting Summary Tools: Track Decisions and Follow-Ups Clearly
2026 Latest Top-Rated Best AI Meeting Summary Tools for Clear Decision Tracking and Effortless Follow-Ups. This curated list showcases powerful, game-changing solutions that boost productivity dramatically by automating meeting notes, identifying key action items, and streamlining team coordination across all projects. Get a free vs paid comparison along with real-world tests and weekly updated rankings to help you find the perfect tool. Explore now to unlock your AI edge!
9 tools
xix.ai
Comments (0)
0/500
Vicarious Surgical's Beta 2 robotic surgery system. | Credit: Vicarious Surgical
Vicarious Surgical (NYSE:RBOT) has been notified by the New York Stock Exchange (NYSE) that it is initiating procedures to delist the company's stock.
The surgical robotics company, based in Waltham, Massachusetts, received the formal notice from the exchange on March 3, 2026. Consequently, trading of the company's shares was suspended at the close of the market that day.
RBOT shares are currently priced at $1.92 each ahead of the NYSE market opening today.
Vicarious stated that the NYSE made its determination because the company's stock failed to meet the continued listing requirement. This standard mandates that listed companies maintain a minimum average global market capitalization of $15 million over a consecutive 30-trading-day period.
The company has a 10-business-day window to appeal the decision following receipt of the notice. Vicarious indicated it is currently evaluating a potential appeal. In the interim, the company has secured approval for its stock to be quoted on the OTCIQ market tier, operated by OTC Markets Group. It anticipates its common stock will begin trading on that platform at the market open today, March 4, 2026, and plans to continue using the "RBOT" ticker symbol.
This marks a second confrontation with delisting for the company, which also fell below NYSE standards in 2023. It subsequently executed a reverse stock split in mid-2024 to regain compliance.
Recent developments at Vicarious Surgical
The potential delisting occurs at a pivotal moment for Vicarious. The company has been progressing with its surgical robotics platform for several years, though the journey has encountered multiple delays.
The Vicarious robot is engineered to improve the efficiency of surgical operations. The company initially targeted the first-in-human trials for mid-2025 but postponed the timeline in November 2023. By March 2024, Vicarious outlined a revised plan to prepare its "V1.0" system for an FDA submission in early to mid-fiscal 2026.
In late 2024, the company announced intentions to conduct a year-end cadaver lab for the V1.0 system. This would be followed by verification, validation, and optimization work prior to formal clinical trials. A new hospital partnership was revealed in May 2025, representing a step toward deploying the surgical robot. However, in August of that year, Vicarious decided to defer the start of clinical trials to allow for further robot development, setting a target for a final design freeze by the end of 2026.
Earlier this year, the company successfully conducted an in-vivo porcine lab study for its robot. According to Vicarious, this achievement supports its ongoing progress toward the planned system design freeze scheduled for late 2026.
Apple Smart Glasses Could Debut at WWDC27, Highlighting Privacy Protection
Bloomberg’s Mark Gurman reports that Apple’s smart glasses, codenamed N50, are slated for a WWDC27 debut in June 2027, with a retail launch expected in autumn 2027. Originally targeted for late this year and early 2027, the device’s release has been
Inside Details Exposed About Next-Gen Gemini: Strained Computing Power, Internal Teams Disagreed on Development Priorities and Resource Allocation
Reports indicate that the launch of Google’s highly anticipated next-generation Gemini model has been pushed back. Internal disagreements over development priorities and resource allocation, combined with limited computing capacity and complex approv
OpenAI Dismisses Growth Slowdown Concerns, Says Multiple Business Units Accelerating
In response to external scrutiny regarding decelerating sales growth and missed internal benchmarks, AI leader OpenAI issued a confident statement on Tuesday, April 28. The company clarified that its consumer products and enterprise services are adva
2026 Latest Best AI SQL Copilots Ranked Top-Rated! XIX.AI curates a powerful game-changing collection for weekly updated real-world tests. These must-try tools help you generate accurate revenue dashboards, analyze sales funnels, and track product metrics swiftly, boosting productivity massively. Explore now to Discover your perfect tool for data-driven decision making! 238 characters
9 tools
xix.ai
2026 Latest Best Top-Rated AI Melody Writing Tools for Song Drafts! XIX.AI has curated a highly powerful game-changing collection that goes through rigorous real-world tests to deliver the best writing experience. You can find detailed free vs paid comparisons, accurate rankings, and must-try options designed to help you create stunning song drafts effortlessly and boost your creative productivity significantly. Explore now to discover your perfect tool!
8 tools
xix.ai
2026 Latest Best Top-rated AI Conversation Trainer Tools for Interview Practice are here on XIX.AI! This curated collection features powerful, game-changing tools that go through rigorous real-world tests to deliver accurate feedback. You’ll find a free vs paid comparison and detailed rankings to help you choose the must-try option that boosts your confidence and skills. Explore now to Discover your perfect tool for interview success!
12 tools
xix.ai
2026 Latest Best Top-rated AI Style Transfer Tools for Creative Experiments! XIX.AI has curated a powerful, game-changing collection of must-try tools that deliver exceptional results through real-world tests and rigorous rankings. These top solutions help creatives boost productivity significantly by accelerating content creation and unlocking endless creative possibilities. Explore now to discover your perfect tool and start creating today!
9 tools
xix.ai
2026 Latest Best Top-Rated AI Dialogue Bubble Tools for Visual Storytelling are here on XIX.AI! This curated collection features powerful, game-changing tools that help creators boost productivity and overcome creative bottlenecks. Get a free vs paid comparison, see real-world tests, and check the latest rankings to find the must-try solutions perfect for crafting engaging visual narratives. Explore now to discover your ideal tool!
10 tools
xix.ai
2026 Latest Top-Rated Best AI Meeting Summary Tools for Clear Decision Tracking and Effortless Follow-Ups. This curated list showcases powerful, game-changing solutions that boost productivity dramatically by automating meeting notes, identifying key action items, and streamlining team coordination across all projects. Get a free vs paid comparison along with real-world tests and weekly updated rankings to help you find the perfect tool. Explore now to unlock your AI edge!
9 tools
xix.ai
